Timothy J. Bettington - 01 Mar 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President, Corporate Strategy and Market Development
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Timothy J. Bettington
Issuer symbol
ELAN
Transactions as of
01 Mar 2024
Net transactions value
$0
Form type
4
Filing time
05 Mar 2024, 16:30:00 UTC
Previous filing
05 Apr 2023
Next filing
05 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +21,835 +20% $0.000000 129,944 01 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option(right to buy) Award $0 +47,620 $0.000000 47,620 01 Mar 2024 Common Stock 47,620 $16.03 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
F2 Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.

Remarks:

Executive Vice President, Corporate Strategy and Market Development